For years, Latinos represented the biggest share of new HIV cases in this city, but testing data suggests the tide may be turning.
Eli Lilly’s obesity drug Zepbound improved liver scarring in mid-stage MASH study
Eli Lilly’s blockbuster diabetes and obesity drug improved living scarring in a mid-stage study of the liver disease MASH, adding to positive data announced earlier